Integrated Filing — IndAS
General information about company
| Scrip Code |
543271 |
| NSE Symbol |
JUBLINGREA |
| MSEI Symbol |
NOTLISTED |
| ISIN |
INE0BY001018 |
| Name of company |
JUBILANT INGREVIA LIMITED |
| Type of company |
Main Board |
| Class of security |
Equity |
| Date of start of financial year |
01-04-2025 |
| Date of end of financial year |
31-03-2026 |
| Date of board meeting when results were approved |
27-10-2025 |
| Date on which prior intimation of the meeting for considering financial results was informed
to the exchange |
|
| Description of presentation currency |
INR |
| Level of rounding used in financial results |
Lakhs |
| Reporting Type |
Quarterly |
| Reporting Quarter |
Second quarter |
| Nature of report standalone or consolidated |
Consolidated |
| Whether results are audited or unaudited for the quarter ended |
Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended |
Unaudited |
| Segment Reporting |
Multi segment |
| Description of single segment |
|
| Start date and time of board meeting |
27-10-2025 13:30:00 |
| End date and time of board meeting |
27-10-2025 15:50:00 |
| Whether cash flow statement is applicable on company |
Yes |
| Type of cash flow statement |
Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification |
Not applicable |
Financial Results Ind-AS
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-07-2025 |
01-04-2025 |
| B |
Date of end of reporting period |
30-09-2025 |
30-09-2025 |
| C |
Whether results are audited or unaudited |
Unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
| 1 |
Income |
|
Revenue from operations |
1,12,073.00 |
2,15,868.00 |
|
Other income |
1,081.00 |
2,203.00 |
|
Total income |
1,13,154.00 |
2,18,071.00 |
| 2 |
Expenses |
| (a) |
Cost of materials consumed |
54,795.00 |
99,686.00 |
| (b) |
Purchases of stock-in-trade |
3,060.00 |
6,300.00 |
| (c) |
Changes in inventories of finished goods,
work-in-progress and stock-in-trade |
2,196.00 |
6,009.00 |
| (d) |
Employee benefit expense |
10,750.00 |
21,573.00 |
| (e) |
Finance costs |
1,216.00 |
2,485.00 |
| (f) |
Depreciation, depletion and amortisation expense
|
4,123.00 |
8,207.00 |
| (f) |
Other Expenses |
| 1 |
- Power and fuel expense |
10,663.00 |
20,659.00 |
| 2 |
- Others |
17,057.00 |
33,875.00 |
|
Total other expenses |
27,720.00 |
54,534.00 |
|
Total expenses |
1,03,860.00 |
1,98,794.00 |
| 3 |
Total profit before exceptional items and tax |
9,294.00 |
19,277.00 |
| 4 |
Exceptional items |
0.00 |
0.00 |
| 5 |
Total profit before tax |
9,294.00 |
19,277.00 |
| 6 |
Tax expense |
|
| 7 |
Current tax |
1,534.00 |
3,851.00 |
| 8 |
Deferred tax |
805.00 |
955.00 |
| 9 |
Total tax expenses |
2,339.00 |
4,806.00 |
| 10 |
Net movement in regulatory deferral account balances related to profit or loss and
the related deferred tax movement |
0.00 |
0.00 |
| 11 |
Net Profit Loss for the period from
continuing operations |
6,955.00 |
14,471.00 |
| 12 |
Profit (loss) from discontinued operations before tax |
0.00 |
0.00 |
| 13 |
Tax expense of discontinued operations |
0.00 |
0.00 |
| 14 |
Net profit (loss) from discontinued
operation after tax |
0.00 |
0.00 |
| 15 |
Share of profit (loss) of associates and joint ventures accounted for using equity
method |
(8.00) |
(14.00) |
| 16 |
Total profit (loss) for period |
6,947.00 |
14,457.00 |
| 17 |
Other comprehensive income net of taxes |
746.00 |
1,753.00 |
| 18 |
Total Comprehensive Income for the period |
7,693.00 |
16,210.00 |
| 19 |
Total profit or loss, attributable to
|
|
|
|
Profit or loss, attributable to owners of parent |
6,947.00 |
14,457.00 |
|
Total profit or loss, attributable to non-controlling interests |
0.00 |
0.00 |
| 20 |
Total Comprehensive income for the period attributable to |
|
|
|
Comprehensive income for the period attributable to owners of parent |
7,693.00 |
16,210.00 |
|
Total comprehensive income for the period attributable to owners of parent non-controlling
interests |
0.00 |
0.00 |
| 21 |
Details of equity share capital |
|
|
Paid-up equity share capital |
1,580.00 |
1,580.00 |
|
Face value of equity share capital |
1580 |
1580 |
| 27 |
Details of debt securities |
|
| 22 |
Reserves excluding revaluation reserve |
|
|
| 23 |
Earnings per share |
|
| i |
Earnings per equity share for continuing operations |
|
|
Basic earnings (loss) per share from continuing operations |
4.4 |
9.15 |
|
Diluted earnings (loss) per share from continuing operations |
4.4 |
9.15 |
| ii |
Earnings per equity share for discontinued operations |
|
|
Basic earnings (loss) per share from discontinued operations |
0 |
0 |
|
Diluted earnings (loss) per share from discontinued operations |
0 |
0 |
| ii |
Earnings per equity share |
|
|
Basic earnings (loss) per share from continuing
and discontinued operations |
4.4 |
9.15 |
|
Diluted earnings (loss) per share from
continuing and discontinued operations |
4.4 |
9.15 |
| 24 |
Debt equity ratio |
0.2500 |
0.2500 |
| 25 |
Debt service coverage ratio |
4.5800 |
4.6500 |
| 26 |
Interest service coverage ratio |
12.0200 |
12.0500 |
| 27 |
Disclosure of notes on financial results |
|
Remarks
Statement of Asset and Liabilities
Amount in (Lakhs)
| Particulars |
Year ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-04-2025 |
| Date of end of reporting period |
30-09-2025 |
| Whether results are audited or unaudited |
Unaudited |
| Nature of report standalone or consolidated |
Consolidated |
|
Assets |
| 1 |
Non-current assets |
|
Property, plant and equipment |
2,59,027.00 |
|
Capital work-in-progress |
63,338.00 |
|
Investment property |
0.00 |
|
Goodwill |
0.00 |
|
Other intangible assets |
2,110.00 |
|
Intangible assets under development |
0.00 |
|
Biological assets other than bearer plants |
0.00 |
|
Investments accounted for using equity method |
671.00 |
|
Non-current financial assets |
|
|
Non-current investments |
1,973.00 |
|
Trade receivables, non-current |
0.00 |
|
Loans, non-current |
40.00 |
|
Other non-current financial assets |
204.00 |
|
Total non-current financial assets |
2,217.00 |
|
Deferred tax assets (net) |
1,314.00 |
|
Other non-current assets |
3,113.00 |
|
Total non-current assets |
3,31,790.00 |
| 2 |
Current assets |
|
|
Inventories |
92,781.00 |
|
Current financial asset |
|
|
Current investments |
0.00 |
|
Trade receivables, current |
76,007.00 |
|
Cash and cash equivalents |
3,684.00 |
|
Bank balance other than cash and cash equivalents |
1,007.00 |
|
Loans, current |
32.00 |
|
Other current financial assets |
5,849.00 |
|
Total current financial assets |
86,579.00 |
|
Current tax assets (net) |
0.00 |
|
Other current assets |
14,507.00 |
|
Total current assets |
1,93,867.00 |
| 3 |
Non-current assets classified as held for sale |
0.00 |
| 4 |
Regulatory deferral account debit balances and related deferred tax Assets |
0.00 |
|
Total assets |
5,25,657.00 |
|
Equity and liabilities |
|
| 1 |
Equity |
|
|
Equity attributable to owners of parent |
|
|
Equity share capital |
1,580.00 |
|
Other equity |
3,02,505.00 |
|
Total equity attributable to owners of parent |
3,04,085.00 |
|
Non controlling interest |
0.00 |
|
Total equity |
3,04,085.00 |
| 2 |
Liabilities |
|
|
Non-current liabilities |
|
|
Non-current financial liabilities |
|
|
Borrowings, non-current |
36,504.00 |
|
Trade payables, non-current |
|
|
(A) Total outstanding dues of micro enterprises and small enterprises |
0.00 |
|
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises |
0.00 |
|
Total Trade payable |
0.00 |
|
Other non-current financial liabilities |
10,928.00 |
|
Total non-current financial liabilities |
47,432.00 |
|
Provisions, non-current |
6,496.00 |
|
Deferred tax liabilities (net) |
23,577.00 |
|
Deferred government grants, Non-current |
0.00 |
|
Other non-current liabilities |
0.00 |
|
Total non-current liabilities |
77,505.00 |
|
Current liabilities |
|
|
Current financial liabilities |
|
|
Borrowings, current |
44,110.00 |
|
Trade payables, current |
|
|
(A) Total outstanding dues of micro enterprises and small enterprises |
5,821.00 |
|
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises |
75,594.00 |
|
Total Trade payable |
81,415.00 |
|
Other current financial liabilities |
12,497.00 |
|
Total current financial liabilities |
1,38,022.00 |
|
Other current liabilities |
3,572.00 |
|
Provisions, current |
1,712.00 |
|
Current tax liabilities (Net) |
761.00 |
|
Deferred government grants, Current |
0.00 |
|
Total current liabilities |
1,44,067.00 |
| 3 |
Liabilities directly associated with assets in disposal group classified as held for sale |
0.00 |
| 4 |
Regulatory deferral account credit balances and related deferred tax liability |
0.00 |
|
Total liabilities |
2,21,572.00 |
|
Total equity and liabilites |
5,25,657.00 |
|
Disclosure of notes on assets and liabilities |
|
Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results
Amount in (Lakhs)
| Particulars |
3 months/ 6 month ended (dd-mm-yyyy) |
Year to date figures for current period
ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-07-2025 |
01-04-2025 |
| Date of end of reporting
period |
30-09-2025 |
30-09-2025 |
| Whether results are audited
or unaudited |
Unaudited |
Unaudited |
| Nature of report standalone or
consolidated |
Consolidated |
Consolidated |
| 1 |
Segment Revenue (Income) |
|
(net sale/income from each segment should
be disclosed) |
| 1 |
Speciality Chemicals |
53,544.00 |
1,07,241.00 |
| 2 |
Nutrition & Health Solutions |
18,061.00 |
35,948.00 |
| 3 |
Chemical Intermediates |
45,705.00 |
83,870.00 |
|
Total Segment Revenue |
1,17,310.00 |
2,27,059.00 |
|
Less: Inter segment revenue |
5,237.00 |
11,191.00 |
|
Revenue from operations |
1,12,073.00 |
2,15,868.00 |
| 2 |
Segment Result |
|
Profit (+) / Loss (-) before tax and
interest from each segment |
| 1 |
Speciality Chemicals |
10,037.00 |
20,660.00 |
| 2 |
Nutrition & Health Solutions |
1,662.00 |
3,661.00 |
| 3 |
Chemical Intermediates |
795.00 |
1,292.00 |
|
Total Profit before tax |
12,494.00 |
25,613.00 |
|
i. Finance cost |
1,216.00 |
2,485.00 |
|
ii. Other Unallocable Expenditure net off Unallocable income |
1,992.00 |
3,865.00 |
|
Profit before tax |
9,286.00 |
19,263.00 |
| 3 |
(Segment Asset - Segment Liabilities)
|
|
Segment Asset |
| 1 |
Speciality Chemicals |
2,88,850.00 |
2,88,850.00 |
| 2 |
Nutrition & Health Solutions |
78,697.00 |
78,697.00 |
| 3 |
Chemical Intermediates |
1,45,152.00 |
1,45,152.00 |
|
Total Segment Asset |
5,12,699.00 |
5,12,699.00 |
|
Un-allocable Assets |
12,958.00 |
12,958.00 |
|
Net Segment Asset |
5,25,657.00 |
5,25,657.00 |
| 4 |
Segment Liabilities |
|
Segment Liabilities |
| 1 |
Speciality Chemicals |
56,274.00 |
56,274.00 |
| 2 |
Nutrition & Health Solutions |
12,596.00 |
12,596.00 |
| 3 |
Chemical Intermediates |
48,805.00 |
48,805.00 |
|
Total Segment Liabilities |
1,17,675.00 |
1,17,675.00 |
|
Un-allocable Liabilities |
1,03,897.00 |
1,03,897.00 |
|
Net Segment Liabilities |
2,21,572.00 |
2,21,572.00 |
|
Disclosure of notes on segments |
|
Other Comprehensive Income
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-07-2025 |
01-04-2025 |
| B |
Date of end of reporting period |
30-09-2025 |
30-09-2025 |
| C |
Whether results are audited or unaudited |
Unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
|
Other comprehensive income [Abstract] |
|
| 1 |
Amount of items that will not be reclassified to profit and loss |
|
| 1 |
i) a) Items that will not be reclassified to profit or loss |
435.00 |
595.00 |
|
Total Amount of items that will not be reclassified to profit and loss |
435.00 |
595.00 |
| 2 |
Income tax relating to items that will not be reclassified to profit or loss |
37.00 |
53.00 |
| 3 |
Amount of items that will be reclassified to profit and loss |
|
| 1 |
ii) a) Items that will be reclassified to profit or loss |
440.00 |
1,619.00 |
|
Total Amount of items that will be reclassified to profit and loss |
440.00 |
1,619.00 |
| 4 |
Income tax relating to items that will be reclassified to profit or loss |
92.00 |
408.00 |
| 5 |
Total Other comprehensive income |
746.00 |
1,753.00 |
Cash flow statement, indirect
Amount in (Lakhs)
| Particulars |
Year ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-04-2025 |
| B |
Date of end of reporting period |
30-09-2025 |
| C |
Whether results are audited or unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Consolidated |
|
Statement of cash flows |
|
|
Cash flows from used in operating
activities |
|
|
Profit before tax |
19,277.00 |
|
Adjustments for reconcile profit (loss) |
|
|
Adjustments for finance costs |
2,485.00 |
|
Adjustments for decrease (increase) in inventories |
1,561.00 |
|
Adjustments for decrease (increase) in trade receivables, current |
(14,962.00) |
|
Adjustments for decrease (increase) in trade receivables, non-current
|
0.00 |
|
Adjustments for decrease (increase) in other current assets |
0.00 |
|
Adjustments for decrease (increase) in other non-current assets |
0.00 |
|
Adjustments for other financial assets, non-current |
(1,768.00) |
|
Adjustments for other financial assets, current |
0.00 |
|
Adjustments for other bank balances |
0.00 |
|
Adjustments for increase (decrease) in trade payables, current |
(77.00) |
|
Adjustments for increase (decrease) in trade payables, non-current |
0.00 |
|
Adjustments for increase (decrease) in other current liabilities |
362.00 |
|
Adjustments for increase (decrease) in other non-current liabilities
|
0.00 |
|
Adjustments for depreciation and amortisation expense |
8,207.00 |
|
Adjustments for impairment loss reversal of impairment loss recognised
in profit or loss |
0.00 |
|
Adjustments for provisions, current |
20.00 |
|
Adjustments for provisions, non-current |
0.00 |
|
Adjustments for other financial liabilities, current |
0.00 |
|
Adjustments for other financial liabilities, non-current |
0.00 |
|
Adjustments for unrealised foreign exchange losses gains |
375.00 |
|
Adjustments for dividend income |
0.00 |
|
Adjustments for interest income |
110.00 |
|
Adjustments for share-based payments |
503.00 |
|
Adjustments for fair value losses (gains) |
0.00 |
|
Adjustments for undistributed profits of associates |
0.00 |
|
Other adjustments for which cash effects are investing or financing
cash flow |
0.00 |
|
Other adjustments to reconcile profit (loss) |
(51.00) |
|
Other adjustments for non-cash items |
0.00 |
|
Share of profit and loss from partnership firm or association of
persons or limited liability partnerships |
0.00 |
|
Total adjustments for reconcile
profit (loss) |
(3,455.00) |
|
Net cash flows from (used in)
operations |
15,822.00 |
|
Dividends received |
0.00 |
|
Interest paid |
0.00 |
|
Interest received |
0.00 |
|
Income taxes paid (refund) |
6,114.00 |
|
Other inflows (outflows) of cash |
0.00 |
|
Net cash flows from (used in)
operating activities |
9,708.00 |
|
Cash flows from used in
investing activities |
|
|
Cash flows from losing control of subsidiaries or other businesses |
0.00 |
|
Cash flows used in obtaining control of subsidiaries or other businesses |
0.00 |
|
Other cash receipts from sales of equity or debt instruments of other
entities |
0.00 |
|
Other cash payments to acquire equity or debt instruments of other entities
|
205.00 |
|
Other cash receipts from sales of interests in joint ventures |
0.00 |
|
Other cash payments to acquire interests in joint ventures |
0.00 |
|
Cash receipts from share of profits of partnership firm or association of
persons or limited liability partnerships |
0.00 |
|
Cash payment for investment in partnership firm or association of persons or
limited liability partnerships |
0.00 |
|
Proceeds from sales of property, plant and equipment |
313.00 |
|
Purchase of property, plant and equipment |
13,367.00 |
|
Proceeds from sales of investment property |
0.00 |
|
Purchase of investment property |
0.00 |
|
Proceeds from sales of intangible assets |
0.00 |
|
Purchase of intangible assets |
0.00 |
|
Proceeds from sales of intangible assets under development |
0.00 |
|
Purchase of intangible assets under development |
0.00 |
|
Proceeds from sales of goodwill |
0.00 |
|
Purchase of goodwill |
0.00 |
|
Proceeds from biological assets other than bearer plants |
0.00 |
|
Purchase of biological assets other than bearer plants |
0.00 |
|
Proceeds from government grants |
0.00 |
|
Proceeds from sales of other long-term assets |
0.00 |
|
Purchase of other long-term assets |
0.00 |
|
Cash advances and loans made to other parties |
0.00 |
|
Cash receipts from repayment of advances and loans made to other parties |
0.00 |
|
Cash payments for future contracts, forward contracts, option contracts and
swap contracts |
0.00 |
|
Cash receipts from future contracts, forward contracts, option contracts and
swap contracts |
0.00 |
|
Dividends received |
0.00 |
|
Interest received |
82.00 |
|
Income taxes paid (refund) |
0.00 |
|
Other inflows (outflows) of cash |
3,552.00 |
|
Net cash flows from (used in)
investing activities |
(9,625.00) |
|
Cash flows from used in
financing activities |
|
|
Proceeds from changes in ownership interests in subsidiaries |
0.00 |
|
Payments from changes in ownership interests in subsidiaries |
0.00 |
|
Proceeds from issuing shares |
0.00 |
|
Proceeds from issuing other equity instruments |
0.00 |
|
Payments to acquire or redeem entity's shares |
1,447.00 |
|
Payments of other equity instruments |
0.00 |
|
Proceeds from exercise of stock options |
60.00 |
|
Proceeds from issuing debentures notes bonds etc |
0.00 |
|
Proceeds from borrowings |
7,755.00 |
|
Repayments of borrowings |
3,958.00 |
|
Payments of lease liabilities |
163.00 |
|
Dividends paid |
3,922.00 |
|
Interest paid |
3,279.00 |
|
Income taxes paid (refund) |
0.00 |
|
Other inflows (outflows) of cash |
0.00 |
|
Net cash flows from (used in)
financing activities |
(4,954.00) |
|
Net increase (decrease) in cash
and cash equivalents before effect of exchange rate changes |
(4,871.00) |
|
Effect of exchange rate changes
on cash and cash equivalents |
|
|
Effect of exchange rate changes on cash and cash equivalents |
1,619.00 |
|
Net increase (decrease) in cash
and cash equivalents |
(3,252.00) |
|
Cash and cash equivalents cash flow statement at beginning of period
|
6,936.00 |
|
Cash and cash equivalents cash
flow statement at end of period |
3,684.00 |